06.04.17
US Patent No. 9,622,955 B2; Advangen International, Sydney, Australia, has patented a method of treatment or prevention of hair loss. It entails administering to a subject an effective amount of a topical formulation comprising midkine to an affected area of skin of the subject in which hair has been lost or to an area of skin from which hair is likely to be lost.
